Data as of Jan 23
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 5.27, with a high estimate of 6.00 and a low estimate of 4.53. The median estimate represents a +641.86% increase from the last price of 0.71.
The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.